NCT00478530View on ClinicalTrials.gov

The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

October 31, 2008

Conditions
Macular Degeneration
Interventions
PROCEDURE

ELECTRORETINOGRAM

Bevacizumab 1.25 mg/0.05 ml unilaterally into the vitreous cavity as part of the standard management for choroidal neovascular AMD. ERG responses form both eyes will be measured at baseline and 1 month after intravitreal injection

Trial Locations (1)

52621

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT00478530 - The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram | Biotech Hunter | Biotech Hunter